Servier Stumbles in Muscle Disease as Drug From $1.5B Deal Fails Pivotal Test
Servier’s sevasemten got here from the acquisition of the muscular dystrophy belongings of Edgewise Therapeutics. Whereas the small molecule had ...
Tag: Servier
Servier Executive: ‘We Are Not Looking for Blockbusters, We’re Looking for Innovative Science’
Servier accomplished its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular enterprise is predicted to shut ...
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics
France-based pharma firm Servier is buying the muscular dystrophy enterprise of Edgewise Therapeutics as a part of a income progress ...
Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma
Day One Biopharmaceuticals is Servier’s greatest acquisition but, topping the $2.4 billion it paid to purchase Shire’s most cancers enterprise ...
Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B
Andrew Joseph covers well being, medication, and the biopharma business in Europe. You may attain Andrew on Sign at drewqjoseph.71.LONDON ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!